Nico Dosenbach is associate professor of neurology at Washington University School of Medicine. His research as a systems neuroscientist is focused on pushing resting-state functional connectivity MRI (RSFC), functional MRI (fMRI) and diffusion tensor imaging (DTI) to the level of individual patients. To create and annotate the connectomes of individuals he is working to improve the signal-to-noise, spatial resolution and replicability of RSFC, DTI and fMRI data.
Nico Dosenbach
Associate professor of neurology
Washington University School of Medicine
From this contributor
Breaking down the winner’s curse: Lessons from brain-wide association studies
We found an issue with a specific type of brain imaging study and tried to share it with the field. Then the backlash began.
Breaking down the winner’s curse: Lessons from brain-wide association studies
By
Nico Dosenbach, Scott Marek
25 March 2024 | 6 min read
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
By
Lauren Schneider
4 February 2026 | 7 min read
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
By
Claudia López Lloreda
3 February 2026 | 4 min read
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
By
Calli McMurray
3 February 2026 | 6 min read